Baystate Wealth Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-502
Closed -$126K 921
2022
Q1
$126K Sell
502
-499
-50% -$125K 0.01% 220
2021
Q4
$257K Buy
+1,001
New +$245K 0.02% 161
2019
Q1
Sell
-35
Closed -$5K 683
2018
Q4
$5K Buy
35
+8
+30% +$1.07K ﹤0.01% 439
2018
Q3
$4K Hold
27
﹤0.01% 456
2018
Q2
$3K Hold
27
﹤0.01% 503
2018
Q1
$3K Hold
27
﹤0.01% 469
2017
Q4
$3K Hold
27
﹤0.01% 469
2017
Q3
$2K Hold
27
﹤0.01% 487
2017
Q2
$2K Hold
27
﹤0.01% 493
2017
Q1
$2K Hold
27
﹤0.01% 462
2016
Q4
$2K Buy
+27
New +$2.02K ﹤0.01% 400

Other funds holding HCA

Baystate Wealth Management's HCA Position: Q2 2022 in Review

Baystate Wealth Management sold out of HCA Healthcare (HCA) in Q2 2022, closing a stake of 502 shares — an estimated $126K sold.

Baystate Wealth Management first reported a position in HCA in Q4 2016 and held it in 11 quarters. The position peaked at $257K in Q4 2021. 883 funds tracked by Wall St. Rank hold HCA as of Q2 2022.

  • Baystate Wealth Management reported no remaining HCA Healthcare position as of Q2 2022 after selling out during the quarter.
  • Baystate Wealth Management sold 502 HCA Healthcare shares in Q2 2022, an estimated $126K.
  • Baystate Wealth Management first reported a position in HCA Healthcare in Q4 2016 and held it in 11 quarters.
  • Baystate Wealth Management's HCA Healthcare position peaked at $257K in Q4 2021.
  • 883 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2022.

Based on Baystate Wealth Management's 13F filing for Q2 2022, filed 2 Aug 2022.